(Q34880930)

English

Rosuvastatin

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

Rosuvastatin. (English)

1 reference

Europe PubMed Central

5 August 2017

2

object named as

Greg L Plosker

1 reference

Europe PubMed Central

5 August 2017

author name string

Christopher I Carswell

1

1 reference

Europe PubMed Central

5 August 2017

Blair Jarvis

3

1 reference

Europe PubMed Central

5 August 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

62

1 reference

Europe PubMed Central

5 August 2017

14

1 reference

Europe PubMed Central

5 August 2017

2075-85; discussion 2086-7

1 reference

Europe PubMed Central

5 August 2017

https://scigraph.springernature.com/pub.10.2165/00003495-200262140-00008

0 references

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cost of treating dyslipidaemia using National Cholesterol Education Program (NCEP) guidelines

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and biological activity of methanesulfonamide pyrimidine- and N-methanesulfonyl pyrrole-substituted 3,5-dihydroxy-6-heptenoates, a novel series of HMG-CoA reductase inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug treatment of lipid disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coronary heart disease: reducing the risk: the scientific background to primary and secondary prevention of coronary heart disease. A worldwide view. International Task force for the Prevention of Coronary Heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A perspective on hyperlipidemia: concepts of management in the prevention of coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosuvastatin demonstrates greater reduction of low-density lipoprotein cholesterol compared with pravastatin and simvastatin in hypercholesterolaemic patients: a randomized, double-blind study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current, new and future treatments in dyslipidaemia and atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12269853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-200262140-00008

1 reference

Europe PubMed Central

5 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

5 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34880930&oldid=1989849534"